378 related articles for article (PubMed ID: 12955640)
1. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
2. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
Melzer M; Eykyn SJ; Gransden WR; Chinn S
Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.
Mylotte JM; Tayara A
Clin Infect Dis; 2000 Nov; 31(5):1170-4. PubMed ID: 11073748
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
Lodise TP; McKinnon PS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):113-22. PubMed ID: 15964499
[TBL] [Abstract][Full Text] [Related]
5. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.
Cosgrove SE; Sakoulas G; Perencevich EN; Schwaber MJ; Karchmer AW; Carmeli Y
Clin Infect Dis; 2003 Jan; 36(1):53-9. PubMed ID: 12491202
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
8. Mortality and neurodevelopmental outcome after Staphylococcus aureus bacteremia in infants.
Cohen-Wolkowiez M; Benjamin DK; Fowler VG; Wade KC; Alexander BD; Worley G; Goldstein RF; Smith PB
Pediatr Infect Dis J; 2007 Dec; 26(12):1159-61. PubMed ID: 18043460
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Staphylococcus aureus.
Wisplinghoff H; Seifert H; Coimbra M; Wenzel RP; Edmond MB
Clin Infect Dis; 2001 Sep; 33(5):733-6. PubMed ID: 11486296
[TBL] [Abstract][Full Text] [Related]
10. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia.
Wang FD; Chen YY; Chen TL; Liu CY
Am J Infect Control; 2008 Mar; 36(2):118-22. PubMed ID: 18313513
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
Lesse AJ; Mylotte JM
Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
14. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.
Soriano A; Martínez JA; Mensa J; Marco F; Almela M; Moreno-Martínez A; Sánchez F; Muñoz I; Jiménez de Anta MT; Soriano E
Clin Infect Dis; 2000 Feb; 30(2):368-73. PubMed ID: 10671343
[TBL] [Abstract][Full Text] [Related]
16. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome.
Fang CT; Shau WY; Hsueh PR; Chen YC; Wang JT; Hung CC; Huang LY; Chang SC
J Antimicrob Chemother; 2006 Mar; 57(3):511-9. PubMed ID: 16443700
[TBL] [Abstract][Full Text] [Related]
17. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
Al-Nammari SS; Bobak P; Venkatesh R
Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort.
Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Kim SW; Chang HH; Kim YS; Jung SI; Son JS; Hsueh PR; So TM; Lalitha MK; Yang Y; Huang SG; Wang H; Lu Q; Carlos CC; Perera JA; Chiu CH; Liu JW; Chongthaleong A; Thamlikitkul V; Van Pham H;
J Infect; 2010 Oct; 61(4):299-306. PubMed ID: 20670652
[TBL] [Abstract][Full Text] [Related]
19. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality of Staphylococcal bacteremia in children.
Hakim H; Mylotte JM; Faden H
Am J Infect Control; 2007 Mar; 35(2):102-5. PubMed ID: 17327189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
